Treatment News : Novel Anti-HIV Gene Therapy Demonstrates Glimmers of Success

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 17, 2010

Novel Anti-HIV Gene Therapy Demonstrates Glimmers of Success

The molecular pieces of an anti-HIV gene therapy—when given to HIV-positive people with lymphoma—persist in the blood for up to two years post-infusion, according to a study announced by researchers at City of Hope hospital in Duarte, California, and published June 16 in Science Translational Medicine. Though the experiment doesn’t prove that the new gene therapy can cure HIV, it does demonstrate that it’s safe and that the body doesn’t reject the treatment.

Much excitement and continued interest surround a stem cell transplant conducted two years ago in Germany that appears to have cured the recipient of his HIV infection. Gero Huetter, MD—the researcher responsible for the single-patient study—transplanted stem cells that carried a natural resistance to HIV infection in an HIV-positive man with leukemia. The new stem cells lacked the ability to produce a cellular coreceptor, called CCR5, which the virus uses when entering a cell. The transplanted cells were able to flourish, and two years later the man has no traces of HIV that can be found—in essence, he was cured of HIV.

Aside from the serious health risks of a stem cell transplant like the one Huetter performed, the procedure isn’t practical for most people, because it is rare to find a stem cell donor who both matches a person genetically—to reduce the risk that the body will reject the cells—and carries the CCR5 mutation. Thus, researchers around the globe are looking for other ways to accomplish the same goal.

In that vein, David DiGiusto, PhD, and his colleagues from City of Hope, designed an anti-HIV gene therapy for testing in four HIV-positive people scheduled to undergo a hematopoietic stem cell transplant for lymphoma. In this type of a procedure, a person’s own stem cells are extracted, combined with anti-HIV genes, expanded and then returned to the body.

Three anti-HIV genes were used by DiGiusto’s group: one that keeps the new cell from producing CCR5 receptors, one that has direct anti-HIV properties, and one that keeps the virus’s TAT protein from aiding the virus in reproducing once a cell is infected.

The cells treated with gene therapy were successfully and safely engrafted, and they appeared to persist at very low levels for up to 24 months following the transfusion.

DiGiusto’s team will now work on improving the process so that future recipients of the gene therapy can be given more of the cells during transplants than in the previous experiment—thus, hopefully allowing more of the cells to persist over time and boosting people’s resistance to HIV.

Search: Gene therapy, RNA interference, TAT, CCR5, lymphoma, Gero Huetter, cure, David DiGiusto, City of Hope


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    CuteBoyinQns
    Jackson Heights
    New York


    Sin_Grinder
    Reno
    Nevada


    sefarady
    New York
    California


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.